THE World Health Organisation (WHO) on Thursday announced the resumption of clinical trials of the anti-malaria drug – Hydroxychloroquine – to determine its efficacy in the prevention and treatment of COVID-19. It concluded that there was no cogent reason to halt the drug use for trial based on review of available data by its Safety […]
